InvestorsHub Logo
Followers 16
Posts 5825
Boards Moderated 0
Alias Born 07/16/2018

Re: Gator328 post# 350736

Friday, 02/11/2022 7:52:37 AM

Friday, February 11, 2022 7:52:37 AM

Post# of 470854
DOESN'T SEEM LIKE MISSLING IS LEARNING FROM HIS MISTAKES GIVEN AVXL SCREWED UP THE PR RELEASED YESTERDAY!!!!!!!

His PR mistakes don’t bother me as long as he learns from them and doesn’t repeat them.





https://ih.advfn.com/stock-market/NASDAQ/anavex-life-sciences-AVXL/stock-news/87242817/anavex-life-sciences-to-present-at-the-11th-annual

Anavex’s lead drug candidate, ANAVEX®2-73 (blarcamesine), successfully completed a Phase 2a clinical trial for Alzheimer’s disease and recently a Phase 2 proof-of-concept study in Parkinson’s disease dementia and a Phase 2 study in adult patients with Rett syndrome.




WE GOT THIS!!!!!!!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News